Literature DB >> 17964437

Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion.

Manish Parikh1, Patricia Ayoung-Chee, Eleny Romanos, Nichole Lewis, H Leon Pachter, George Fielding, Christine Ren.   

Abstract

BACKGROUND: Bariatric operation is the most effective treatment for diabetes mellitus in the morbidly obese. The purpose of this study is to compare the rate of resolution of diabetes mellitus after three common laparoscopic bariatric procedures: laparoscopic adjustable gastric banding (LAGB), Roux-en-Y gastric bypass (RYGB), and biliopancreatic diversion with or without duodenal switch (BPD/DS). STUDY
DESIGN: All data were prospectively collected and entered into an electronic registry. Characteristics evaluated for this study included preoperative age, body mass index, duration of diabetes, race, gender, operative time, length of stay, percent excess weight loss, oral hypoglycemic requirements, and insulin requirements.
RESULTS: A total of 282 bariatric patients with diabetes mellitus were analyzed (218 LAGB, 53 RYGB, and 11 BPD/DS). Preoperative age (46 to 50 years), body mass index (46 to 50; calculated as kg/m(2)), race and gender breakdown, and baseline oral hypoglycemic (82% to 87%) and insulin requirements (18% to 28%) were comparable among the three groups (p = NS). Percent excess weight loss at 1, 2, and 3 years was: 43%, 50%, and 45% for LAGB; 66%, 68%, and 66% for RYGB; and 68%, 77%, and 82% for BPD/DS (p < 0.01 LAGB versus RYGB and LAGB versus BPD/DS at all time intervals). At 1 and 2 years, the proportion of patients requiring oral hypoglycemics postoperatively was 39% and 34% for LAGB; 22% and 13% for RYGB; and 11% and 13% for BPD/DS (p = NS). At 1 and 2 years, the proportion of patients requiring insulin postoperatively was 14% and 18% for LAGB; 7% and 13% for RYGB; and 11% and 13% for BPD/DS (p = NS).
CONCLUSIONS: Despite the disparity in percent excess weight loss between LAGB, RYGB, and BPD/DS, the rate of resolution of diabetes mellitus is equivalent.

Entities:  

Mesh:

Year:  2007        PMID: 17964437     DOI: 10.1016/j.jamcollsurg.2007.05.033

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  17 in total

1.  Metabolic laparoscopic gastric bypass for obese patients with type 2 diabetes.

Authors:  Mário Nora; Marta Guimarães; Rui Almeida; Paulo Martins; Gil Gonçalves; Maria José Freire; Tiago Ferreira; Cláudia Freitas; Mariana P Monteiro
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

2.  The big fat bariatric bandwagon.

Authors:  J H Pinkney; A B Johnson; E A M Gale
Journal:  Diabetologia       Date:  2010-09       Impact factor: 10.122

3.  Abnormal glucose tolerance testing following gastric bypass demonstrates reactive hypoglycemia.

Authors:  Mitchell Roslin; Tanuja Damani; Jonathan Oren; Robert Andrews; Edward Yatco; Paresh Shah
Journal:  Surg Endosc       Date:  2010-12-24       Impact factor: 4.584

Review 4.  A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding.

Authors:  Juan Victor A Franco; Pablo Adrian Ruiz; Mariano Palermo; Michel Gagner
Journal:  Obes Surg       Date:  2011-09       Impact factor: 4.129

5.  Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity.

Authors:  Tom C Hall; Mike G C Pellen; Peter C Sedman; Prashant K Jain
Journal:  Obes Surg       Date:  2010-09       Impact factor: 4.129

6.  [Indications and principles of metabolic surgery].

Authors:  R A Weiner
Journal:  Chirurg       Date:  2010-04       Impact factor: 0.955

7.  The Impact of Laparoscopic Adjustable Gastric Banding on an NHS Cohort of Type 2 Diabetics: a Prospective Cohort Study.

Authors:  Richard J Egan; Andrew B Johnson; Justin D T Morgan; Sally A Norton
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

8.  Early U.S. outcomes after laparoscopic adjustable gastric banding in patients with a body mass index less than 35 kg/m2.

Authors:  Samuel Sultan; Manish Parikh; Heekoung Youn; Marina Kurian; George Fielding; Christine Ren
Journal:  Surg Endosc       Date:  2009-03-05       Impact factor: 4.584

9.  Is there any role of resecting the stomach to ameliorate weight loss and sugar control in morbidly obese diabetic patients?

Authors:  Eldo E Frezza; Susan E Wozniak; Laura Gee; Mitchell Wacthel
Journal:  Obes Surg       Date:  2009-05-30       Impact factor: 4.129

10.  Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism.

Authors:  Tammy L Kindel; Stephanie M Yoder; Randy J Seeley; David A D'Alessio; Patrick Tso
Journal:  J Gastrointest Surg       Date:  2009-05-12       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.